Avantax Planning Partners Inc. Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Avantax Planning Partners Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 0.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 5,620 shares of the healthcare conglomerate’s stock after selling 30 shares during the period. Avantax Planning Partners Inc.’s holdings in UnitedHealth Group were worth $2,866,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. State Street Corp lifted its holdings in shares of UnitedHealth Group by 1.9% during the fourth quarter. State Street Corp now owns 45,559,868 shares of the healthcare conglomerate’s stock valued at $22,877,432,000 after purchasing an additional 869,827 shares in the last quarter. Capital International Investors grew its position in shares of UnitedHealth Group by 4.3% during the fourth quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after purchasing an additional 790,219 shares in the last quarter. Geode Capital Management LLC grew its position in shares of UnitedHealth Group by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 15,618,069 shares of the healthcare conglomerate’s stock worth $7,821,210,000 after purchasing an additional 189,864 shares in the last quarter. Alliancebernstein L.P. grew its holdings in UnitedHealth Group by 2.4% during the 4th quarter. Alliancebernstein L.P. now owns 11,015,163 shares of the healthcare conglomerate’s stock valued at $5,531,154,000 after buying an additional 257,910 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $4,478,185,000. 87.48% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH traded up $1.31 during mid-day trading on Friday, reaching $535.06. The stock had a trading volume of 2,373,351 shares, compared to its average volume of 2,833,444. The business has a 50 day simple moving average of $506.46 and a 200 day simple moving average of $499.44. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 0.77. The firm has a market capitalization of $500.48 billion, a price-to-earnings ratio of 27.94, a PEG ratio of 1.65 and a beta of 0.76.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company had revenue of $80.33 billion during the quarter, compared to the consensus estimate of $79.68 billion. During the same period last year, the firm earned $4.70 EPS. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th were paid a dividend of $1.65 per share. The ex-dividend date was Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a dividend yield of 1.23%. UnitedHealth Group’s payout ratio is currently 34.46%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Cowen lifted their target price on UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $549.00 to $556.00 in a research report on Tuesday, July 19th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a report on Wednesday, May 25th. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a report on Thursday, May 26th. They noted that the move was a valuation call. Finally, Raymond James upped their price target on UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research report on Tuesday, April 19th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $582.50.

Insider Activity

In other news, Director Frederick William Mcnabb III acquired 89 shares of the business’s stock in a transaction on Thursday, May 26th. The shares were purchased at an average price of $504.32 per share, for a total transaction of $44,884.48. Following the acquisition, the director now directly owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other UnitedHealth Group news, Director Frederick William Mcnabb III acquired 89 shares of the stock in a transaction that occurred on Thursday, May 26th. The stock was acquired at an average price of $504.32 per share, with a total value of $44,884.48. Following the transaction, the director now directly owns 11,259 shares in the company, valued at $5,678,138.88. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. Insiders sold 130,144 shares of company stock valued at $69,269,555 in the last ninety days. Company insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.